Ryan Christopher Lennox, General Counsel at HLS Therapeutics Inc, holds 500.00 shares in HLS Therapeutics Inc (Ticker: TSE:HLS). Most recently, Ryan Christopher Lennox Bought C$500 shares of HLS Therapeutics Inc on Aug 31, 2019 for an estimated value of 6.75K.